Gastric Cancer: Epidemiologic Aspects

Helicobacter

Volumn 18, Issue S1, 2013, Pages 34-38

  González, Carlos A ^a   Sala, Núria ^a   Rokkas, Theodore ^b  

^a CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^b HENRY DUNANT HOSPITAL   (Greece)

Author keywords

Environmental factors; Genetic factors; Review

Indexed keywords

ALDEHYDROGENASE2; ANTIOXIDANT; AROMATASE; DOC2 PROTEIN; ERCC5 PROTEIN; FLAVONOID; HEME; HFE PROTEIN; INTERLEUKIN 10; INTERLEUKIN 8; LYMPHOTOXIN; MICRORNA; MICRORNA 181A; MICRORNA 196A2; MICRORNA 221; MICRORNA 27A; MICRORNA 376C; MICRORNA 744; NUCLEIC ACID BINDING PROTEIN; PLCE1 PROTEIN; PROSTATE STEM CELL ANTIGEN; PROTEIN P53; TRANSCRIPTION FACTOR EZH2; UNCLASSIFIED DRUG; UVOMORULIN; XERODERMA PIGMENTOSUM GROUP;

CANCER PROGNOSIS; CANCER RISK; CARDIA; COHORT ANALYSIS; DISEASE ASSOCIATION; ENVIRONMENTAL FACTOR; FRUIT; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HEREDITY; HUMAN; IRON INTAKE; MEDICAL INFORMATION; META ANALYSIS (TOPIC); OBESITY; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SALT INTAKE; STOMACH CANCER; TEA;

ENVIRONMENTAL FACTORS; GENETIC FACTORS; REVIEW;

ANIMALS; COHORT STUDIES; ENVIRONMENT; HUMANS; STOMACH NEOPLASMS;

EID: 84883778293     PISSN: 10834389     EISSN: 15235378     Source Type: Journal    
DOI: 10.1111/hel.12082     Document Type: Review

References (39)

1. de Martel C, Ferlay J, Franceschi S, Vignat J, Bray F, Forman D, Plummer M. Global burden of cancers attributable to infections in 2008: a review and synthetic analysis. Lancet Oncol 2012;13:607-15.
2. Dikken JL, Dassen AE, Lemmens VE, Putter H, Krijnen P, van der Geest L, et al. Effect of hospital volume on postoperative mortality and survival after oesophageal and gastric cancer surgery in the Netherlands between 1989 and 2009. Eur J Cancer 2012;48:1004-13.
3. Xue H, Liu J, Lin B, Wang Z, Sun J, Huang G. A meta-analysis of interleukin-8 -251 promoter polymorphism associated with gastric cancer risk. PLoS ONE 2012;7:e28083.
4. Pan F, Tian J, Pan YY, Zhang Y. Association of IL-10-1082 promoter polymorphism with susceptibility to gastric cancer: evidence from 22 case-control studies. Mol Biol Rep 2012;39:7143-54.
5. Lu R, Dou X, Gao X, Zhang J, Ni J, Guo L. A functional polymorphism of lymphotoxin-alpha (LTA) gene rs909253 is associated with gastric cancer risk in an Asian population. Cancer Epidemiol 2012;36:e380-6.
6. He J, Qiu LX, Wang MY, Hua RX, Zhang RX, Yu HP, et al. Polymorphisms in the XPG gene and risk of gastric cancer in Chinese populations. Hum Genet 2012;131:1235-44.
7. Duan Z, He C, Gong Y, Li P, Xu Q, Sun LP, et al. Promoter polymorphisms in DNA repair gene ERCC5 and susceptibility to gastric cancer in Chinese. Gene 2012;511:274-9.
8. Xu S, Zhou Y, Du WD, Chen G, Zhou FS, Schneider M, et al. Association of the variant rs2243421 of human DOC-2/DAB2 interactive protein gene (hDAB2IP) with gastric cancer in the Chinese Han population. Gene 2013;515:200-4.
9. Liu KJ, Qi HZ, Yao HL, Lei SL, Lei ZD, Li TG, Zhao H. An updated meta-analysis of the p53 codon 72 polymorphism and gastric cancer risk. Mol Biol Rep 2012;39:8265-75.
10. Cho LY, Yang JJ, Ko KP, Ma SH, Shin A, Choi BY, et al. Genetic susceptibility factors on genes involved in the steroid hormone biosynthesis pathway and progesterone receptor for gastric cancer risk. PLoS ONE 2012;7:e47603.
11. Agudo A, Bonet C, Sala N, Muñoz X, Aranda N, Fonseca A, et al. Hemochromatosis (HFE) gene mutations and risk of gastric cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Carcinogenesis 2013;34:1244-50.
12. Duell EJ, Sala N, Travier N, Muñoz X, Boutron-Ruault MC, Clavel-Chapelon F, et al. Genetic variation in alcohol dehydrogenase (ADH1A, ADH1B, ADH1C, ADH7) and aldehyde dehydrogenase (ALDH2), alcohol consumption and gastric cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. Carcinogenesis 2012;33:361-7.
13. Zhan Z, Wu J, Zhang JF, Yang YP, Tong S, Zhang CB, et al. CDH1 gene polymorphisms, plasma CDH1 levels and risk of gastric cancer in a Chinese population. Mol Biol Rep 2012;39:8107-13.
14. Zhou Y, Du WD, Wu Q, Liu Y, Chen G, Ruan J, et al. EZH2 genetic variants affect risk of gastric cancer in the Chinese Han population. Mol Carcinog 2012 Jan 6. doi: 10.1002/mc.21871. [Epub ahead of print].
15. Liu Y, Li L, Qi H, Gao Y, Liu S, Xu C. Survivin -31G>C polymorphism and gastrointestinal tract cancer risk: a meta-analysis. PLoS ONE 2013;8:e54081.
16. Shi D, Wang S, Gu D, Wu D, Wang M, Chu H, et al. The PSCA polymorphisms derived from genome-wide association study are associated with risk of gastric cancer: a meta-analysis. J Cancer Res Clin Oncol 2012;138:1339-45.
17. Song MY, Pan KF, Su HJ, Zhang L, Ma JL, Li JY, et al. Identification of serum microRNAs as novel non-invasive biomarkers for early detection of gastric cancer. PLoS ONE 2012;7:e33608.
18. Yan Z, Xiong Y, Xu W, Gao J, Cheng Y, Wang Z, et al. Identification of hsa-miR-335 as a prognostic signature in gastric cancer. PLoS ONE 2012;7:e40037.
19. Yang Q, Jie Z, Ye S, Li Z, Han Z, Wu J, et al. Genetic variations in miR-27a gene decrease mature miR-27a level and reduce gastric cancer susceptibility. Oncogene 2012 Dec 17. doi: 10.1038/onc.2012.569. [Epub ahead of print].
20. Lin Y, Nie Y, Zhao J, Chen X, Ye M, Li Y, et al. Genetic polymorphism at miR-181a binding site contributes to gastric cancer susceptibility. Carcinogenesis 2012;33:2377-83.
21. Wang S, Tao G, Wu D, Zhu H, Gao Y, Tan Y, et al. A functional polymorphism in MIR196A2 is associated with risk and prognosis of gastric cancer. Mol Carcinog 2013 Feb 19. doi: 10.1002/mc.22017. [Epub ahead of print].
22. Wang W, Li F, Mao Y, Zhou H, Sun J, Li R, et al. A miR-570 binding site polymorphism in the B7-H1 gene is associated with the risk of gastric adenocarcinoma. Hum Genet 2013;132:641-8.
23. Li Y, Nie Y, Cao J, Tu S, Lin Y, Du Y, Li Y. G-A variant in miR-200c binding site of EFNA1 alters susceptibility to gastric cancer. Mol Carcinog 2012 Oct 12. doi: 10.1002/mc.21966. [Epub ahead of print].
24. Jin G, Ma H, Wu C, Dai J, Zhang R, Shi Y, et al. Genetic variants at 6p21.1 and 7p15.3 are associated with risk of multiple cancers in Han Chinese. Am J Hum Genet 2012;91:928-34.
25. Wang M, Zhang R, He J, Qiu L, Li J, Wang Y, et al. Potentially functional variants of PLCE1 identified by GWASs contribute to gastric adenocarcinoma susceptibility in an eastern Chinese population. PLoS ONE 2012;7:e31932.
26. Gonzalez CA, Lujan-Barroso L, Bueno-de-Mesquita HB, Jenab M, Duell EJ, Agudo A, et al. Fruit and vegetable intake and the risk of gastric adenocarcinoma: a reanalysis of the European Prospective Investigation into Cancer and Nutrition (EPIC-EURGAST) study after a longer follow-up. Int J Cancer 2012;131:2910-9.
27. Serafini M, Jakszyn P, Luján-Barroso L, Agudo A, Bas Bueno-de-Mesquita H, van Duijnhoven FJ, et al. Dietary total antioxidant capacity and gastric cancer risk in the European prospective investigation into cancer and nutrition study. Int J Cancer 2012;131:E544-54.
28. Zamora-Ros R, Agudo A, Luján-Barroso L, Romieu I, Ferrari P, Knaze V, et al. Dietary flavonoid and lignan intake and gastric adenocarcinoma risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Am J Clin Nutr 2012;96:1398-408.
29. Sasazuki S, Tamakoshi A, Matsuo K, Ito H, Wakai K, Nagata C, et al. Green tea consumption and gastric cancer risk: an evaluation based on a systematic review of epidemiologic evidence among the Japanese population. Jpn J Clin Oncol 2012;42:335-46.
30. D'Elia L, Rossi G, Ippolito R, Cappuccio FP, Strazzullo P. Habitual salt intake and risk of gastric cancer: a meta-analysis of prospective studies. Clin Nutr 2012;31:489-98.
31. Ren JS, Kamangar F, Forman D, Islami F. Pickled food and risk of gastric cancer-a systematic review and meta-analysis of English and Chinese literature. Cancer Epidemiol Biomarkers Prev 2012;21:905-15.
32. Ward MH, Cross AJ, Abnet CC, Sinha R, Markin RS, Weisenburger DD. Heme iron from meat and risk of adenocarcinoma of the esophagus and stomach. Eur J Cancer Prev 2012;21:134-8.
33. Cook MB, Kamangar F, Weinstein SJ, Albanes D, Virtamo J, Taylor PR, et al. Iron in relation to gastric cancer in the Alpha-tocopherol, Beta-carotene Cancer Prevention Study. Cancer Epidemiol Biomarkers Prev 2012;21:2033-42.
34. Keszei AP, Goldbohm RA, Schouten LJ, Jakszyn P, van den Brandt PA. Dietary N-nitroso compounds, endogenous nitrosation, and the risk of esophageal and gastric cancer subtypes in the Netherlands Cohort Study. Am J Clin Nutr 2013;97:135-46.
35. Agudo A, Peluso M, Munnia A, Luján-Barroso L, Sánchez MJ, Molina-Montes E, et al. Aromatic DNA adducts and risk of gastrointestinal cancers: a case-cohort study within the EPIC-Spain. Cancer Epidemiol Biomarkers Prev 2012;21:685-92.
36. Algra AM, Rothwell PM. Effects of regular aspirin on long-term cancer incidence and metastasis: a systematic comparison of evidence from observational studies versus randomised trials. Lancet Oncol 2012;13:518-27.
37. O'Doherty MG, Freedman ND, Hollenbeck AR, Schatzkin A, Abnet CC. A prospective cohort study of obesity and risk of oesophageal and gastric adenocarcinoma in the NIH-AARP Diet and Health Study. Gut 2012;61:1261-8.
38. Persson EC, Shiels MS, Dawsey SM, Bhatia K, Anderson LA, Engels EA. Increased risk of stomach and esophageal malignancies in people with AIDS. Gastroenterology 2012;143:943-950.e2.
39. Bonequi P, Meneses-González F, Correa P, Rabkin CS, Camargo MC. Risk factors for gastric cancer in Latin America: a meta-analysis. Cancer Causes Control 2013;24:217-31.